The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...

Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...

The system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.

The Tendyne system is designated for those who are at high risk for traditional open-heart surgery. It helps with those with ...

Abbott's Tendyne transcatheter mitral valve replacement (TMVR) system was approved by the FDA and indicated for those with ...

The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular ...

The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...

Abbott today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendynetm transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease.

Objective: To examine the current literature behind the evolution of mitral valve surgery techniques and their impact on patient outcomes. Methods: An electronic literature search among major ...

Mitral valve prolapse, also known as click-murmur syndrome ... Cardiac catheterization. With this procedure, X-rays are taken after a contrast agent is injected into an artery to locate any narrowing, ...